Stanford University
Showing 251-300 of 538 Results
-
Jin Hyung Lee
Associate Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery and of Bioengineering and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsIn vivo visualization and control of neural circuits
-
Marly LeSene
Program Director, Communications & Initiatives, Bioengineering
Current Role at StanfordProgram Director, Communications & Initiatives
-
Craig Levin
Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsMolecular Imaging Instrumentation
Laboratory
Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects. -
Michael Lin
Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur lab applies biochemical and engineering principles to the development of protein-based tools for investigating biology in living animals. Topics of investigation include fluorescent protein-based voltage indicators, synthetic light-controllable proteins, bioluminescent reporters, and applications to studying animal models of disease.
-
Jonathan T.C. Liu, PhD
Professor of Pathology and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsBiomedical optics
In vivo microscopy
Slide-free pathology
Three-dimensional microscopy
3D pathology
Optical biopsy
Image-guided surgery
Early detection
Artificial intelligence
Machine learning
Deep learning
Computational analysis
Computational pathology
Virtual staining
Molecular imaging -
Emma Lundberg
Associate Professor of Bioengineering and of Pathology
BioDr. Emma Lundberg is an Associate Professor of Bioengineering and Pathology at Stanford University and serves at the Director of the Cell Atlas of the Human Protein Atlas initiative in Sweden, where she is also Professor at KTH Royal Institute of Technology. At the intersection of bioimaging, proteomics, and artificial intelligence, her research aims to define the spatiotemporal organization of the human proteome at both cellular and subcellular level. Dr. Lundberg aims to develop integrated models of human cells to elucidate how variations in protein localization patterns influence cellular function, ultimately enabling the simulation of cell behavior and a systems-level understanding of how biological information is spatially encoded. The Lundberg Lab is responsible for creating the Subcellular Atlas of the Human Protein Atlas database (https://www.proteinatlas.org/). Dr. Lundberg is dedicated to building virtual cell models to simulate cell behavior, and is passionate about engaging the public in her work through citizen science games and computational challenges.
Dr. Lundberg holds a Master’s degree in Bioengineering and a PhD in Biotechnology from KTH Royal Institute of Technology in Sweden. She has served as Secretary General of the Human Proteome Organization, and is actively involved in advisory roles for numerous open-access databases and cell mapping efforts such as the CZI AI Virtual Cell, Human Cell Atlas consortium, UniProt db, Reactome db, Human Proteome Project and various pharma and biotech companies. As a token of her leadership skills and advocate for open science, she was twice recognized as top 10 under 40 for future leaders in biopharma and omics. -
Viviana Macarelli
Postdoctoral Scholar, Bioengineering
BioViviana earned her PhD in Clinical Biochemistry from the University of Cambridge (UK) in 2024, where she focused on the role of primary cilia in metabolic sensing by the hypothalamus. She then joined the Lundberg lab as a postdoc for a project in collaboration with the Chan Zuckerberg Imaging Institute. She will focus on characterizing primary cilia in the adult brain using human induced pluripotent stem cells (hIPSC).
-
Joshua Makower
Yock Family Professor and Professor of Bioengineering
Current Research and Scholarly InterestsDr. Josh Makower is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Director of the Stanford Byers Center for Biodesign, the program he co-founded with Dr. Paul Yock twenty years ago. Josh helped create the fundamental structure of the Center’s core curriculum and is the chief architect of what is now called “The Biodesign Process.” Over the past 20 years since Josh and Paul founded Biodesign, this curriculum and the associated textbook has been used at Stanford and across the world to train hundreds of thousands of students, faculty and industry leaders on the Biodesign process towards the advancement of medical innovation for the improvement of patient care. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 9 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, NC8 and Willow. Josh is also a Special Partner at NEA where he supports the healthcare team and medtech/healthtech investing practice. Josh serves on the boards of Allay Therapeutics, Revelle Aesthetics, Setpoint Medical, DOTS Technologies, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering and the College of Fellows of The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.
-
Jocasta Manasseh-Lewis
Ph.D. Student in Bioengineering, admitted Autumn 2025
Current Research and Scholarly InterestsMotivational control of behavior, optogenetics, neuropsychiatric disoders
-
Nick Manfred
Ph.D. Student in Neurosciences, admitted Autumn 2022
Ph.D. Minor, BioengineeringCurrent Research and Scholarly InterestsInvestigating Batten disease pathology and treatment via multi-omic approaches
-
Mariya Mardamshina
Postdoctoral Scholar, Bioengineering
BioMariya Mardamshina, MD, PhD, is a postdoctoral fellow in the Department of Bioengineering, working in Prof. Emma Lundberg's lab. She earned her medical degree from Semey State Medical University and completed her PhD at Tel Aviv University, where her research focused on spatial inter- and intratumoral heterogeneity in breast cancer using mass spectrometry-based proteomics. Currently, her work in the Lundberg lab centers on deciphering cell-to-cell proteomic variability within a spatial framework. Her research involves developing integrated pipelines that combine automated multiplexed staining, high-resolution microscopy, artificial intelligence, and ultra-high sensitivity mass spectrometry to achieve comprehensive proteomic analyses.
